FTXHvsPJPETF Comparison
VS
First Trust Nasdaq Pharmaceuticals ETF (FTXH) and Invesco Dynamic Pharmaceuticals ETF (PJP) belong to the same industry segment: US Health Care. Both ETFs have the same top 1 sector exposures: Healthcare. FTXH is more expensive with a Total Expense Ratio (TER) of 0.6%, versus 0.58% for PJP. FTXH is up 31.84% year-to-date (YTD) with +$1.02B in YTD flows. PJP performs worse with 22.03% YTD performance, and +$174M in YTD flows. Run a side-by-side ETF comparison of FTXH and PJP below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
FTXH vs PJP performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 10/28/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | FTXH PJP | +3.28%-0.48% | +9.09%+3.40% | +31.84%+22.03% | +47.80%+34.56% | +87.39%+89.92% | +77.36%+68.86% |
| Flows | FTXH PJP | +$41M-$6M | +$176M+$81M | +$1.02B+$174M | +$1.02B+$189M | +$1.02B+$132M | +$1.02B-$17M |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | FTXH PJP | +18.78%+17.34% | +17.62%+17.51% | +17.11%+16.42% | +16.43%+16.60% |
| Max drawdown | FTXH PJP | -5.45%-7.99% | -7.50%-9.42% | -19.32%-16.11% | -19.32%-17.41% |
| Max drawdown duration | FTXH PJP | 57d70d | 99d108d | 393d275d | 393d788d |
Trading data
FTXH | PJP | |
Last sale 10/29/2026 at 1:30 PM | $43.77 | $128.88 |
| Previous close 10/28/2026 | $43.25 | $126.67 |
| Consolidated volume 10/28/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of September 30, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
FTXH | PJP | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 10/29/2026 at 1:30 PM
Live
Closed
FTXH | PJP | |
|---|---|---|
| Last price | $43.77 | $128.88 |
| 1D performance | +1.22% | +1.74% |
| AuM | $1.16 B | $561.92 M |
| E/R | 0.6% | 0.58% |
Characteristics
FTXH | PJP | |
|---|---|---|
| Management strategy | Passive | Passive |
| Provider | First Trust | Invesco |
| Benchmark | NASDAQ US Smart Pharmaceuticals Index | Dynamic Pharmaceutical Intellidex Index |
| N° of holdings | 49 | 28 |
| Asset class | Equities | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | September 20, 2016 | June 23, 2005 |
| ESG | No | No |
Advertisement
Exposure
Countries
FTXH
USA
95.82%
Other
4.18%
PJP
USA
94.16%
Other
5.84%
Sectors
FTXH
Healthcare
99.79%
Other
0.21%
PJP
Healthcare
100%
Other
-0%
Advertisement
Diversification
FTXH
Total weight of top 15 holdings out of 15
67.15%
PJP
Total weight of top 15 holdings out of 15
66.71%
Top 15 holdings
Data as of August 31, 2026
FTXH
Merck & Co., Inc.
7.62%
AbbVie, Inc.
7.05%
Eli Lilly & Co.
6.92%
Johnson & Johnson
6.87%
Bristol Myers Squibb Co.
6.75%
Amgen, Inc.
3.56%
Biogen, Inc.
3.54%
Viatris, Inc.
3.51%
Vertex Pharmaceuticals, Inc.
3.48%
Regeneron Pharmaceuticals, Inc.
3.33%
Cardinal Health, Inc.
3.29%
Pfizer Inc.
3.25%
Gilead Sciences, Inc.
3.16%
Incyte Corp.
2.43%
United Therapeutics Corp.
2.39%
PJP
Amgen, Inc.
5.72%
Abbott Laboratories
5.66%
Merck & Co., Inc.
5.49%
AbbVie, Inc.
5.33%
Johnson & Johnson
5.08%
Gilead Sciences, Inc.
4.89%
Eli Lilly & Co.
4.86%
Corcept Therapeutics, Inc.
4.79%
Pfizer Inc.
4.77%
Travere Therapeutics, Inc.
3.77%
Amneal Pharmaceuticals, Inc.
3.48%
Harmony Biosciences Holdings, Inc.
3.28%
Ocular Therapeutix, Inc.
3.23%
Perrigo Co. Plc
3.22%
Regeneron Pharmaceuticals, Inc.
3.15%
Frequently asked questions about FTXH and PJP
How have the FTXH and PJP ETFs performed in 2026?
As of October 28, 2026, FTXH is up 31.84% year-to-date (YTD), while PJP has returned 22.03%. That puts FTXH better performer ahead so far this year.
Which ETF is attracting more investor money: FTXH or PJP?
Year-to-date, the FTXH ETF saw +$1.02B in flows, compared to +$174M for PJP.
Which ETF is more volatile: FTXH or PJP?
Over the past year, FTXH had a volatility of 17.62%, while PJP experienced 17.51%.
Which ETF is bigger: FTXH or PJP?
As of October 28, 2026, FTXH holds $1.16 B in assets under management (AUM), while PJP manages $561.92 M.
What sectors do the FTXH and PJP ETFs invest in?
FTXH leans toward sectors like Healthcare. Meanwhile, PJP focuses on Healthcare.
What are the top holdings of the FTXH ETF and PJP ETF?
FTXH top holdings include Merck & Co., Inc., AbbVie, Inc. and Eli Lilly & Co.. PJP holds in its top three: Amgen, Inc., Abbott Laboratories and Merck & Co., Inc..
Which ETF is more diversified: FTXH or PJP?
FTXH holds 49 securities with 67.15% of its assets in the top 15. PJP has 28 securities and a top 15 weight of 66.71%.
Advertisement
Advertisement
